Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing

HPV and Gynecologic Cancer

Cervical Cancer Screening: Comparison of conventional Pap smear test, liquid-based cytology and human papillomavirus testing as stand-alone or co-testing strategies

Cancer Epidemiol Biomarkers Prev.

Liang LA, Einzmann T, Franzen A, Schwarzer K, Schauberger G, Schriefer D, Radde K, Zeissig SR, Ikenberg H, Meijer CJ, Kirkpatrick CJ, Kölbl H, Blettner M, Klug SJ

doi: 10.1158/1055-9965.EPI-20-1003.

HPV and Gynecologic Cancer

Prevalence and Risk Factors of Human Papillomavirus Infection in 18-Year-Old Women: Baseline Report of a Prospective Study on Human Papillomavirus Vaccine

J Low Genit Tract Dis.

Igidbashian S, Boveri S, Bottari F, Vidal Urbinati A, Preti E, Casadio C, Landoni F, Sideri M, Sandri MT.

doi: 10.1097/

HPV and Gynecologic Cancer

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial

JAMA.

Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ

doi: 10.1001/jama.2018.7464.

HPV and Gynecologic Cancer

A proper triage for detecting women with high-risk human papillomavirus genotypes other than HPV16/18

Eur J Obstet Gynecol Reprod Biol.

Wang JJ, Lyu LP, Hu QW, Wan ZQ, Dong J, Pan M, Shen WW, Zhang S

doi: 10.1016/j.ejogrb.2017.10.021.

HPV and Gynecologic Cancer

Modeling the balance of benefits and harms of cervical cancer screening with cytology and human papillomavirus testing

Cancer Epidemiol Biomarkers Prev.

Malagón T, Mayrand MH, Ogilvie G, Gotlieb WH, Blake J, Bouchard C, Franco EL, Kulasingam S

doi: 10.1158/1055-9965.EPI-20-0190.

HPV and Gynecologic Cancer

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial

Lancet.

Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, Mayrand MH, Ruiz-Sternberg AM, Stapleton JT, Wiley DJ, Ferenczy A, Kurman R, Ronnett BM, Stoler MH, Cuzick J, Garland SM, Kjaer SK, Bautista OM, Haupt R, Moeller E, Ritter M, Roberts CC, Shields C, Luxembourg A

doi: 10.1016/

HPV and Gynecologic Cancer

Genetic variations in human papillomavirus and cervical cancer outcomes

Int J Cancer.

Rader JS, Tsaih SW, Fullin D, Murray MW, Iden M, Zimmermann MT, Flister MJ

doi: 10.1002/ijc.32038.

HPV and Gynecologic Cancer

Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis

Lancet HIV.

Kelly H, Weiss HA, Benavente Y, de Sanjose S, Mayaud P; ART and HPV Review Group

doi: 10.1016/

Reproductive Health

Reproductive Outcomes After Breast Cancer in Women With vs Without Fertility Preservation

JAMA Oncol

Marklund A, Lundberg FE, Eloranta S, Hedayati E, Pettersson K, Rodriguez-Wallberg KA

doi: 10.1001/jamaoncol.2020.5957

Related content

Cervical Cancer Screening: Comparison of conventional Pap smear test, liquid-based cytology and human papillomavirus testing as stand-alone or co-testing strategies

Prevalence and Risk Factors of Human Papillomavirus Infection in 18-Year-Old Women: Baseline Report of a Prospective Study on Human Papillomavirus Vaccine

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial

A proper triage for detecting women with high-risk human papillomavirus genotypes other than HPV16/18

Modeling the balance of benefits and harms of cervical cancer screening with cytology and human papillomavirus testing

Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial

Genetic variations in human papillomavirus and cervical cancer outcomes

Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis

Reproductive Outcomes After Breast Cancer in Women With vs Without Fertility Preservation